Back
ESC2025 Premium Access

Predictors of lipid-lowering therapy intensification over 1 year of prospective follow-up in Europe: insights from the SANTORINI study

Session: Changing face of lipid-lowering therapy
Topic: Drug therapy
Speaker: Doctor C. Aguiar (Lisbon, PT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Carlos Aguiar

Hospital Santa Cruz, Lisbon (Portugal)
17 presentations
42 followers

5 more presentations in this session

Temporal trends in lipid-lowering therapy utilization among ASCVD patients: a large-scale database analysis

Speaker: Doctor M. Goldberg (Tel Aviv, IL)

Access
Abstract
Slides
Video
Like
Thumbnail

Real-world prescribing patterns for lipid-lowering therapy in high cardiovascular risk patients in germany: a cross-sectional analysis

Speaker: Professor O. Weingaertner (Jena, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Oral PCSK9 inhibitors as an emerging frontier in lipid management: a meta-analysis

Speaker: Mr V. Ho (Debrecen, HU)

Access
Abstract
Slides
Video
Like
Thumbnail

Efficacy of obicetrapib across the spectrum of background lipid lowering therapies-pooled analyses of the Broadway and Brooklyn randomised trials

Speaker: Professor K. Ray (London, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Statin adherence in primary care among patients with hypertension with and without other cardiometabolic diseases

Speaker: Doctor J. Sandslatt (Gothenburg, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Changing face of lipid-lowering therapy

Speakers: Doctor C. Aguiar, Doctor M. Goldberg, Professor O. Weingaertner, Mr V. Ho, Professor K. Ray...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources